Purchase Order SPE2DP24P0663

Award Date 7/24/24
Potential Completion Date 9/23/24
Potential Value $7.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and consumables. The contract, valued at $1,287.60, is for the delivery of washing solution, which is a critical medical supply used in various healthcare and biomedical research initiatives supported by federal agencies. Fenwal, Inc. has a long history of providing highly specialized products and services to the U.S....
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical equipment and supplies. The contract, valued at $2,691.69, is for the delivery of washing solution, a critical medical consumable. Fenwal, Inc. is a subsidiary of Fresenius Kabi and a registered vendor with the U.S. federal government, having secured numerous contract awards from various agencies including the DLA, National Institutes of...
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical equipment and supplies. The contract is for the delivery of WASHING SOLUTION,FR, a specialized medical product. The total ceiling value of the contract is $1,287.60, with a period of performance ending on March 4, 2024. There was no set-aside designation used for this award. Fenwal, Inc. is a global blood technology company and a critical...
This federal contract award, with ID SPE2DP25P0040, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical equipment and supplies. The $8,243.54 firm-fixed-price purchase order is for the delivery of washing solution, a critical medical product used in healthcare and biomedical research. Fenwal, Inc. is a global leader in blood collection, separation, storage, and transfusion technologies. The...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the provision of washing solution, which is a specialized medical product used in healthcare and biomedical research applications. The contract has a ceiling value of $11,351.91 and an ultimate completion date of October 17, 2023. Fenwal, Inc. is a...
This firm fixed-price purchase order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,188.92 contract is for the supply of washing solution, FR (flame retardant) to support federal agencies such as the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. Fenwal has a long history of providing a wide range of medical supplies and...
This firm fixed-price purchase order (SPE2DP20V0090) was awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and consumables. The $1,081.44 contract is for the supply of a diluting solution (8506977469) and does not have a set-aside designation. Fenwal, Inc. is a critical supplier to various federal agencies, providing products that support healthcare and biomedical research initiatives, including military...
This federal contract award from the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, is for the supply of washing solution for medical use. The $2,317.68 firm fixed-price purchase order has a period of performance through March 4, 2024. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007. The company has consistently secured federal contract awards from...
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract is for the procurement of washing solution, FR (Federal Stock Code 8506838380), with a ceiling value of $6,994.50 and a period of performance ending on September 23, 2019. The contract was awarded on September 16, 2019 and does not have a set-aside designation. Fenwal, Inc. is...
This is a $16,608.88 firm fixed-price purchase order contract awarded by the Defense Health Agency to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical equipment and supplies. The contract is for the provision of intravenous fluids for use in the agency's blood bank operations. This award does not have a set-aside designation, reflecting Fenwal's specialized expertise in transfusion medicine and cell therapy technologies. Fenwal has a history of providing critical medical...

This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical supplies and equipment. The contract, valued at $7,596.84, is for the delivery of washing solution, which is a critical medical product used in blood collection, separation, and transfusion procedures. Fenwal, Inc. is a key supplier to various federal agencies, including the Department of Veterans Affairs, National Institutes of Health, and Defense Health Agency, providing an extensive array of specialized medical technologies and services in the field of transfusion medicine and cell therapy. This contract does not have a set-aside designation, reflecting Fenwal's unique capabilities and expertise in this domain. The award is not associated with a larger contract vehicle.

Generated 7/11/25, 10:06 AM